Clinical trial

Study of XL647 in Subjects With Non-Small-Cell Lung Cancer

NCT00364780

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE2

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2022-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small-cell Lung Cancerunresolved

Interventions

XL647DRUG

Sponsors & collaborators

Kadmon Corporation, LLClead sponsor

Mapped research locations

New YorkNew York, United States1 BostonMassachusetts, United States1 ChicagoIllinois, United States1 ClevelandOhio, United States1 DetroitMichigan, United States1 UrbanaIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00364780 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.